Why the study?
Emergency balloon aortic valvuloplasty followed by Impella support as a bridge to definitive therapy in severe aortic stenosis complicated by cardiogenic shock has limited reports.
Case Report (n=4)
No
The BAV-PELLA strategy is a feasible and potentially life-saving bridge to definitive therapy for patients with severe aortic stenosis complicated by cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Supports feasibility of BAV-PELLA bridging in select AS shock cases; hypothesis-generating and requires prospective validation before practice change.
Objective: Severe aortic stenosis (AS) is a life-threatening valvular disease with an in-hospital mortality rate exceeding 50% when complicated by cardiogenic shock. In this critical setting, emergency balloon aortic valvuloplasty (BAV) is sometimes performed as an initial therapy. However, reports on emergency BAV followed by Impella (Abiomed, Danvers, MA, USA) support, referred to as the BAV-PELLA strategy, remain limited.
No takes yet. Share an insight, caveat, or question.
Nishida et al. (2026) conducted a case report in Severe aortic stenosis complicated by cardiogenic shock (n=4). Emergency balloon aortic valvuloplasty followed by Impella support (BAV-PELLA strategy) was evaluated on Successful transition to definitive valve replacement therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: